ALYSSA HURTADO: Open Payments
NPI 1417441122 · ONEIDA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,916 in 91 payments from 39 companies in 2025. Trend: 2023 $670 · 2024 $586 · 2025 $1,916
Food & beverage: $1,816Education: $100
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 13 | $182 |
| Genentech USA, Inc. | 9 | $172 |
| Merck Sharp & Dohme LLC | 6 | $139 |
| Astellas Pharma US Inc | 2 | $114 |
| PharmaEssentia USA Corporation | 4 | $96 |
| Lilly USA, LLC | 4 | $80 |
| ABBVIE INC. | 3 | $79 |
| Daiichi Sankyo Inc. | 3 | $74 |
| TerSera Therapeutics LLC | 3 | $72 |
| Alexion Pharmaceuticals, Inc. | 3 | $72 |
Products named: KEYTRUDA, KISQALI, BESREMI, BRUKINSA, Venclexta, Zoladex, ULTOMIRIS, Polivy.
Industry payments across NY — which companies pay providers there.
